The plasma-lyte 148 v saline (PLUS) study protocol: A multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality

Critical Care and Resuscitation

Volumn 19, Issue 3, 2017, Pages 239-246

  Hammond, Naomi E ^a,b,c   Bellomo, Rinaldo ^d   Gallagher, Martin ^a,c,e   Gattas, David ^e,f   Glass, Parisa ^a,c   Mackle, Diane ^g   Micallef, Sharon ^a   Myburgh, John ^a,h,i   Saxena, Manoj ^a,h,i   Taylor, Colman ^a,c   Young, Paul ^f,j   Finfer, Simon ^a,b,c  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^h ST GEORGE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j WELLINGTON HOSPITAL   (New Zealand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; CREATININE; GLUCONIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ARTIFICIAL VENTILATION; AUSTRALIA; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FLUID THERAPY; HEALTH SERVICE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; METABOLISM; MORTALITY; MULTICENTER STUDY; NEW ZEALAND; PROCEDURES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; RESUSCITATION; TIME FACTOR; UTILIZATION;

AUSTRALIA; CREATININE; CRITICAL ILLNESS; FLUID THERAPY; GLUCONATES; HEALTH SERVICES; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MAGNESIUM CHLORIDE; MORTALITY; NEW ZEALAND; POTASSIUM CHLORIDE; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; RESUSCITATION; SODIUM ACETATE; SODIUM CHLORIDE; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 85031687569     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369: 1243-51.
2. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care 2010; 14: R185.
3. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014; 42: 1585-91.
4. Shaw A, Bagshaw S, Goldstein S, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255: 821-9.
5. Yunos N, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308: 1566-72.
6. Yunos NM, Bellomo R, Glassford N, et al. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: An extended analysis. Intensive Care Med 2014; 41: 257-64.
7. Sen A, Keener CM, Sileanu FE, et al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. Crit Care Med 2017; 45: E146-e153.
8. Suetrong B, Pisitsak C, Boyd JH, et al. Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients. Crit Care 2016; 20: 315.
9. Raghunathan K, Bonavia A, Nathanson BH, et al. Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock. Anesthesiology 2015; 123: 1385-93.
10. Shaw AD, Schermer CR, Lobo DN, et al. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care 2015; 19: 334.
11. Shaw AD, Raghunathan K, Peyerl FW, et al. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 2014; 40: 1897-905.
12. Verma B, Luethi N, Cioccari L, et al. A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients. Crit Care Resusc 2016; 18: 205-12.
13. Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Metaanalysis of high-versus low-chloride content in perioperative and critical care fluid resuscitation. Brit J Surg 2015; 102: 24-36.
14. Young P, Bailey M, Beasley R, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: The SPLIT randomized clinical trial. JAMA 2015; 314: 1701-10.
15. Young P, Machado FR, Finfer S. What’s new on balanced crystalloid solutions? Intensive Care Med 2016; 42: 2046-8.
16. Semler MW, Wanderer JP, Ehrenfeld JM, et al. Balanced crystalloids versus saline in the intensive care unit: The SALT randomized trial. Am J Respir Crit Care Med 2017; 195: 1362-72.
17. Hammond NE, Taylor C, Finfer S, et al. Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study. PLoS One 2017; 12: E0176292.
18. Hammond N, Taylor C, Saxena M, et al. Resuscitation fluid use in Australian and New Zealand intensive care units between 2007 and 2013. Intensive Care Med 2015; 41: 1611-9.
19. Glassford NJ, French CJ, Bailey M, Martensson J, Eastwood GM, Bellomo R. Changes in intravenous fluid use patterns in Australia and New Zealand: Evidence of research translating into practice. Crit Care Resusc 2016; 18: 78-8.
20. Cecconi M, Hofer C, Teboul JL, et al. Fluid challenges in intensive care: The FENICE study: A global inception cohort study. Intensive Care Med 2015; 41: 1529-37.
21. Hammond N, Finfer S. Fluid resuscitation in the critically ill: What is the next challenge? Rev Bras Ter Intensiva 2015; 27: 309-11.
22. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.
23. Myburgh J, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11.
24. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-10.
25. Vincent J, Moreno R, Takala J, et al. The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsisrelated problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
26. Knaus W, Draper E, Wagner D, Zimmerman J. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-29.
27. Ridgeon E, Bellomo R, Myburgh J, et al. Validation of a classification system for causes of death in critical care: An assessment of interrater reliability. Crit Care Resusc 2016; 18: 50-4.
28. National Health and Medical Research Council. National statement on ethical conduct in human research, 2007 (updated May 2015). Chapter 4.4: People highly dependent on medical care who may be unable to give consent. Canberra: NHMRC, 2015. https://www.nhmrc.gov.au/guidelines-publications/e72 (accessed May 2017).
29. Health Research Council of New Zealand. Guidelines on ethics in health research. May 2002 (revised 2005; currently under review). Auckland: HRC, 2005. http://www.hrc.govt.nz/sites/ default/files/Ethics%20Guidelines%20Oct%202005%20 -%20under%20review_0.pdf (accessed May 2017).
30. Health and Disability Commissioner. Code of health and disability services consumers’ rights. Wellington: HDC, 2014. http://www.hdc.org.nz/the-act--code/the-code-of-rights (accessed May 2017).
31. Taylor C, Thompson K, Finfer S, et al. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: Long-term outcomes and cost-effectiveness analysis of a cohort from CHEST. Lancet Respir Med 2016; 4: 818-25
32. Zampieri FG, Azevedo LCP, Corrêa TD, et al. Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): A factorial randomised trial. Crit Care Resusc 2017; 18: 175-182.